Healthcare
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
17 Dec 2024  |  Global  |  Market Research
Cybersecurity in Healthcare, United States, 2024
Increasing Cyberattacks and Stricter Regulations Drive Solution Adoption Among Healthcare Providers
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastructure relies on an extensive supply chain involving ...
$2,450.00 -
13 Dec 2024  |  Global  |  Technology Research
Recent Innovations in Precision Medicine Innovations for Cancer and Immunological Diseases
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provide insights across new biologics, and precision cancer therapy innovations. The research also comprises small molecule, cell and gene therapy and gene editing advancements for Niemann–Pick Disease and autoimmune diseases.The Life Science, Health & Wellness ...
$950.00 -
12 Dec 2024  |  Global  |  Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Approval of New Tests and Laboratory Automation Solutions are Driving Transformational Growth
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustai...
$2,450.00 -
05 Dec 2024  |  Global  |  Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, and post-care phases. Conversational AI solutions a...
$4,950.00 -
28 Nov 2024  |  Global  |  Market Research
The Electrophysiology Lab Devices Market, Global, 2021-2029
New Age Technologies and AI are Driving Transformational Growth
This Frost & Sullivan analysis covers innovative devices propelling industry growth as well as the market trends and emerging business models that will dominate the electrophysiology (EP) devices market. Highlights include a look at cutting-edge solutions in EP devices, including EP lab systems and EP diagnostic and ablation catheters, as well as t...
$4,950.00 -
27 Nov 2024  |  Global  |  Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
Gen AI-based Solutions are Driving Transformational Growth across the Payer and Provider Ecosystem as Organizations Move from Identification to Implementation
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journey. Gen AI seamlessly syncs with existing tools/IT ...
$4,950.00 -
22 Nov 2024  |  Global  |  Technology Research
Innovations and Growth Opportunities in Neuromodulation, Surgical Robotic Platforms, and Artificial Intelligence-based Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, medical imaging, and diagnostics industry. The issue includes advanced medical devices such as minimally invasive bone resurfacing implant, continuous glucose monitoring and automated insulin delivery, dir...
$950.00 -
15 Nov 2024  |  Global  |  Technology Research
Recent Innovations in Precision Medicine for Immunological, Inflammatory and Oncological Indications
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in targeted therapies for cancer, immunological and inflammatory diseases. The research also covers technological developments across vaccines, neuroprotective medicines, cell therapies, monoclonal antibody and oncolytic virus platform...
$950.00 -
11 Nov 2024  |  Global  |  Frost Radar
Frost Radar™: US Population Health Management, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Operational, clinical, and financial challenges that result in inefficient resource utilization and suboptimal healthcare outcomes waste money and time and ultimately affect payers and providers’ ability to focus on preventive care and population health improvement. Frost & Sullivan defines population health management (PHM) as solutions and serv...
$4,950.00 -
08 Nov 2024  |  Global  |  Market Research
Growth Opportunities in Enterprise Imaging, Global, 2023-2028
Enterprise Imaging is Experiencing Transformational Growth in its Shift to a Cloud-native Software-as-a-Service Business Model with AI Integrations as a Growth Lever
Medical imaging is no longer limited to radiology, and radiology software solutions are facing challenges in accessing and integrating patient data across health networks. As a result, healthcare providers are adopting enterprise imaging (EI) strategies to consolidate all patient data into a single platform to provide better access and improved dat...
$4,950.00